SIGN UP
LOG IN
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga·05/06/2025 12:08:19
Listen to the news
U.S. stock futures were lower this morning, with the Dow futures falling over 200 points on Tuesday.
Shares of Ichor Holdings, Ltd. (NASDAQ:ICHR) fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results and issued second-quarter guidance below estimates.
Ichor Hldgs reported quarterly earnings of 12 cents per share which missed the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $244.47 million which missed the analyst consensus estimate of $244.95 million.
Ichor Holdings shares dipped 14.8% to $17.75 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Hyperscale Data, Inc. (NYSE:GPUS) dipped 17.2% to $6.42 in pre-market trading. Hyperscale Data shares jumped 466% on Monday after the company issued FY25 sales guidance.
- Immutep Limited (NASDAQ:IMMP) fell 13.3% to $2.16 in pre-market trading. Immutep shares jumped over 45% on Monday after the company provided updates for cohort B of its Tacti-003 Phase IIb trial.
- Palantir Technologies Inc. (NASDAQ:PLTR) fell 8.4% to $113.45 in pre-market trading. Palantir reported in-line earnings for its first quarter on Monday. Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates. The company also raised its full-year guidance.
- Castle Biosciences, Inc. (NASDAQ:CSTL) fell 7.7% to $17.30 in pre-market trading following downbeat quarterly earnings.
- Arcus Biosciences, Inc. (NYSE:RCUS) fell 7.1% to $8.31 in pre-market trading.
- Fabrinet (NYSE:FN) fell 6.8% to $206.00 in today's pre-market trading after the company reported third-quarter results and issued fourth-quarter guidance with its midpoint below estimates.
- EverQuote, Inc. (NASDAQ:EVER) declined 5.1% to $25.00 in pre-market trading following first-quarter results.
- Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) fell 5% to $475.00 in pre-market trading after the company reported worse-than-expected first-quarter financial results.
Now Read This:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.